Alagon, Alona C.

HRN: 25-58-74  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/30/2024
08/06/2024
IV INFUSION
2.25gm
Q8H
Urosepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: